MAVEs: Multiplex Assays of Variant Effect: Saying Goodbye to VUSs?

Wednesday, January 27, 2027 at 2:30 PM to 3:00 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 1 - Wednesday 27th January
CancerDiagnosticsLiquid BiopsyPrecision Medicine

Information

This session will explore:

  • Moving beyond VUSs: How multiplex assays can generate functional evidence to help resolve variants of uncertain significance.  
  • From variant to function: Using high-throughput functional assays to understand the impact of thousands of genetic variants at scale.  
  • Bringing functional data into clinical interpretation: How MAVE data can complement existing genomic and clinical evidence to improve variant classification.  
  • What comes next: The opportunities and challenges of integrating MAVE data into routine cancer genomics and patient care.